Use of Wearable Sensors to Assess Fall Risk in Neurological Disorders: Systematic Review.

IF 6.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Mirjam Bonanno, Augusto Ielo, Paolo De Pasquale, Antonio Celesti, Alessandro Marco De Nunzio, Angelo Quartarone, Rocco Salvatore Calabrò
{"title":"Use of Wearable Sensors to Assess Fall Risk in Neurological Disorders: Systematic Review.","authors":"Mirjam Bonanno, Augusto Ielo, Paolo De Pasquale, Antonio Celesti, Alessandro Marco De Nunzio, Angelo Quartarone, Rocco Salvatore Calabrò","doi":"10.2196/67265","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Assessing fall risk, especially in individuals with neurological disorders, is essential to prevent hospitalization, hypomobility, and reduced functional independence. Wearable sensors are increasingly used in neurorehabilitation, as they enable unsupervised fall risk assessment by providing continuous monitoring during daily functional tasks, thereby offering a reflection of the individual's real-world fall risk.</p><p><strong>Objective: </strong>We systematically reviewed the literature on reliable biomechanical gait parameters detected with wearable sensors to assess fall risk in neurological disorders, focusing on patients with Parkinson disease, multiple sclerosis, stroke, or Alzheimer disease. In addition, we examined the latest advancements in wearable sensor technology, including best practices for device placement as well as data processing and analysis.</p><p><strong>Methods: </strong>We conducted a comprehensive systematic search for relevant peer-reviewed articles published up to April 18, 2025, using PubMed, Web of Science, Embase, and IEEE Xplore, which are the most used databases in the fields of health and bioengineering.</p><p><strong>Results: </strong>The 19 included studies involved 2630 patients with neurological disorders, including 226 (8.59%) with multiple sclerosis (n=7, 37% studies), 2305 (87.64%) with Parkinson disease (n=8, 53% studies), 51 (1.94%) with stroke (n=3, 16% studies), and 48 (1.83%) with Alzheimer disease or cognitive impairment (n=1, 5% study).</p><p><strong>Conclusions: </strong>This review highlights the role of wearable technologies in assessing fall risk in patients with neurological disorders. Although the included studies showed variation in methods and a focus on technology over clinical context, the lack of standardization reflects ongoing advancements, which may be seen as a strength.</p><p><strong>Trial registration: </strong>PROSPERO CRD42023463944; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023463944.</p>","PeriodicalId":14756,"journal":{"name":"JMIR mHealth and uHealth","volume":"13 ","pages":"e67265"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR mHealth and uHealth","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2196/67265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Assessing fall risk, especially in individuals with neurological disorders, is essential to prevent hospitalization, hypomobility, and reduced functional independence. Wearable sensors are increasingly used in neurorehabilitation, as they enable unsupervised fall risk assessment by providing continuous monitoring during daily functional tasks, thereby offering a reflection of the individual's real-world fall risk.

Objective: We systematically reviewed the literature on reliable biomechanical gait parameters detected with wearable sensors to assess fall risk in neurological disorders, focusing on patients with Parkinson disease, multiple sclerosis, stroke, or Alzheimer disease. In addition, we examined the latest advancements in wearable sensor technology, including best practices for device placement as well as data processing and analysis.

Methods: We conducted a comprehensive systematic search for relevant peer-reviewed articles published up to April 18, 2025, using PubMed, Web of Science, Embase, and IEEE Xplore, which are the most used databases in the fields of health and bioengineering.

Results: The 19 included studies involved 2630 patients with neurological disorders, including 226 (8.59%) with multiple sclerosis (n=7, 37% studies), 2305 (87.64%) with Parkinson disease (n=8, 53% studies), 51 (1.94%) with stroke (n=3, 16% studies), and 48 (1.83%) with Alzheimer disease or cognitive impairment (n=1, 5% study).

Conclusions: This review highlights the role of wearable technologies in assessing fall risk in patients with neurological disorders. Although the included studies showed variation in methods and a focus on technology over clinical context, the lack of standardization reflects ongoing advancements, which may be seen as a strength.

Trial registration: PROSPERO CRD42023463944; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023463944.

Abstract Image

Abstract Image

Abstract Image

使用可穿戴传感器评估神经系统疾病患者跌倒风险:系统综述。
背景:评估跌倒风险,特别是神经系统疾病患者,对于预防住院、行动能力低下和功能独立性降低至关重要。可穿戴传感器越来越多地用于神经康复,因为它们可以在日常功能任务中提供连续监测,从而实现无监督的跌倒风险评估,从而反映个人的真实跌倒风险。目的:我们系统地回顾了用可穿戴传感器检测可靠的生物力学步态参数来评估神经系统疾病患者跌倒风险的文献,重点是帕金森病、多发性硬化症、中风或阿尔茨海默病患者。此外,我们还研究了可穿戴传感器技术的最新进展,包括设备放置以及数据处理和分析的最佳实践。方法:利用健康与生物工程领域最常用的数据库PubMed、Web of Science、Embase和IEEE Xplore,对截至2025年4月18日发表的相关同行评议文章进行全面系统检索。结果:纳入的19项研究涉及2630例神经系统疾病患者,其中多发性硬化症226例(8.59%)(n=7, 37%研究),帕金森病2305例(87.64%)(n=8, 53%研究),脑卒中51例(1.94%)(n=3, 16%研究),阿尔茨海默病或认知障碍48例(1.83%)(n=1, 5%研究)。结论:本综述强调了可穿戴技术在评估神经系统疾病患者跌倒风险中的作用。虽然纳入的研究显示了方法的差异和对临床环境技术的关注,但缺乏标准化反映了正在进行的进步,这可能被视为一种优势。试验注册:PROSPERO CRD42023463944;https://www.crd.york.ac.uk/PROSPERO/view/CRD42023463944。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JMIR mHealth and uHealth
JMIR mHealth and uHealth Medicine-Health Informatics
CiteScore
12.60
自引率
4.00%
发文量
159
审稿时长
10 weeks
期刊介绍: JMIR mHealth and uHealth (JMU, ISSN 2291-5222) is a spin-off journal of JMIR, the leading eHealth journal (Impact Factor 2016: 5.175). JMIR mHealth and uHealth is indexed in PubMed, PubMed Central, and Science Citation Index Expanded (SCIE), and in June 2017 received a stunning inaugural Impact Factor of 4.636. The journal focusses on health and biomedical applications in mobile and tablet computing, pervasive and ubiquitous computing, wearable computing and domotics. JMIR mHealth and uHealth publishes since 2013 and was the first mhealth journal in Pubmed. It publishes even faster and has a broader scope with including papers which are more technical or more formative/developmental than what would be published in the Journal of Medical Internet Research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信